{"id":2296,"date":"2020-02-28T18:40:48","date_gmt":"2020-02-28T10:40:48","guid":{"rendered":"https:\/\/credevo.com\/articles\/?p=2296"},"modified":"2021-08-18T20:50:04","modified_gmt":"2021-08-18T12:50:04","slug":"rare-disease-day-2020-taking-a-step-further","status":"publish","type":"post","link":"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/","title":{"rendered":"Rare Disease Day 2020: Taking a step further"},"content":{"rendered":"\n<p>Many people with rare diseases struggle to find the right diagnosis and right treatment for years. The lack of awareness about these conditions makes it much harder for them to get the right treatment. <strong>Rare Disease Day<\/strong> is all about raising awareness for rare diseases. And, this year, you can join these efforts too.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/rarediseaseday_feb29_2020_13th_orphandrug_credevo-1024x576.png\" alt=\"\" class=\"wp-image-2354\" srcset=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/rarediseaseday_feb29_2020_13th_orphandrug_credevo-1024x576.png 1024w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/rarediseaseday_feb29_2020_13th_orphandrug_credevo-300x169.png 300w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/rarediseaseday_feb29_2020_13th_orphandrug_credevo-768x432.png 768w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/rarediseaseday_feb29_2020_13th_orphandrug_credevo-732x412.png 732w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/rarediseaseday_feb29_2020_13th_orphandrug_credevo-1140x641.png 1140w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/rarediseaseday_feb29_2020_13th_orphandrug_credevo.png 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>The first Rare Disease Day was founded in 2008 on February 29th, since then, the day has grown to incorporate numerous health organizations and regulatory agencies across the world, including events in 94 countries last year. <\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What is a rare disease?<\/h2>\n\n\n\n<p><strong>A rare<\/strong> disease which is also referred to as an orphan disease is any disorder that affects a small percentage of the population. Every country has its own definition based on the population it affects. <\/p>\n\n\n\n<h4 class=\"wp-block-heading\">United States<\/h4>\n\n\n\n<p>In the United States, a rare disease is defined as a condition that affects fewer than 200,000 people.  <\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Europe<\/h4>\n\n\n\n<p>A disease or disorder is defined as rare in Europe when it affects less than 1 in 2000.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Japan<\/h4>\n\n\n\n<p>In Japan, a rare disease is one that affects fewer than 50,000 patients Japan, or about 1 in 2,500 people.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Australia<\/h4>\n\n\n\n<p>Australia Therapeutic Goods Authority &#8211; <strong>TGA<\/strong>, describes rare diseases are a condition, syndrome, or disorder that affects 1 in 10,000 people or less.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Russia<\/h4>\n\n\n\n<p>In Russia, a disease is considered to be orphan if there are not more than 10 cases per 100 000 population.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What is a rare disease day?<\/h2>\n\n\n\n<p>The main objective of Rare Disease Day is to raise awareness amongst the general public and decision-makers about rare diseases and their impact on patients&#8217; lives. European Organisation for Rare Diseases was established this day in 2008&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">When is the rare disease day?<\/h2>\n\n\n\n<p>Rare Disease Day takes place on the last day of February each year. <strong>29 February 2020<\/strong> will be the <strong>thirteenth international Rare Disease Day<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Some facts about rare diseases<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>Over 300 million people living with one or more of over 7,000 identified rare diseases around the world which is about Rare diseases currently affect 3.5% &#8211; 5.9% of the worldwide population.<\/li><li>Approximately 72% of rare diseases are genetic and others are the result of infections (bacterial or viral), allergies, and environmental causes, or are degenerative and proliferative.<\/li><li>70% of those genetic rare diseases start in childhood and this is because pediatric cancer is defined as a rare disease.<\/li><li>80 percent of rare diseases are caused by a change or mutation in a person\u2019s DNA (Genetic).<\/li><li>Still, about 95 percent of rare diseases do not have FDA-approved treatments.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Significance of rare disease day<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>The long-term cause of the Rare Disease Day campaign was to achieve access to diagnosis, treatment, health and social care, and social opportunity for people affected by a rare disease.<\/li><li>When it started in 2008, events took place in just 18 countries, and in 2020, Rare Disease Day is being celebrated across multiple countries. <\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">The market for rare diseases<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>There is a huge leap towards rare disease drug developments in the pharma industries. Many leading pharma companies, start-ups, and small to medium scale biopharma companies have already started working on orphan drugs.<\/li><li>Medicines for Rare diseases will see significant growth from 2019 to 2025 in the market size.<\/li><li>The orphan drug market is expected to reach $169 Bn from $106 Bn and register a CAGR of 6.8% during the year 2016 -2022 according to&nbsp;a report.<\/li><li>North America had the largest market share in orphan drugs in the year 2015 and continues to retain its share.<\/li><li>A rise in investment in the rare diseases treatment sector and the introduction of new orphan drugs will boost the market growth in the coming years.&nbsp;<\/li><li>Increase in orphan drug demand has been increased in the last several years, with an increase in awareness of rare diseases.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Regulatory support for rare diseases drug development<\/h2>\n\n\n\n<p>Various government medical agencies are implementing initiatives in order to support and encourage drug developers to work upon developing rare diseases drugs, such as financial incentives, fast track approvals, and regulatory benefits. <\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Agencies of some of the countries like the US, Europe, Japan have been supporting drug developments for rare disease treatment for quite some time.<\/li><li>Some other drug regulatory agencies have also started to work for better support to drug developers engaged in the rare diseases segment.<\/li><li>Regulatory incentives provided in various countries were described in detail in this article, please click on the following links to know in detail<ul><li><a href=\"https:\/\/credevo.com\/articles\/2019\/12\/15\/rare-diseases-regulatory-incentives-for-development-of-orphan-drugs-us-europe\/\" target=\"_blank\" rel=\"noreferrer noopener\">Rare Diseases: Regulatory Incentives for Development of Orphan Drugs \u2013 US &amp; EU<\/a><\/li><li><a href=\"https:\/\/credevo.com\/articles\/2020\/01\/15\/rare-diseases-regulatory-incentives-for-development-of-orphan-drugs-japan-australia\/\">Rare Diseases: Regulatory Incentives for Development of Orphan Drugs \u2013 Japan &amp; Australia<\/a><\/li><li><a href=\"https:\/\/credevo.com\/articles\/2020\/02\/15\/rare-diseases-regulatory-incentives-for-development-of-orphan-drugs-china-india-russia-south-korea\/\">Rare Diseases: Regulatory Incentives for Development of Orphan Drugs \u2013 Asia<\/a> <\/li><\/ul><\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Credevo support for rare diseases<\/h2>\n\n\n\n<p>Credevo has been supportive of rare disease day since its inception in creating awareness of research in rare diseases. <\/p>\n\n\n\n<p>Some of the helpful articles, projects and services that have been a part of Credevo&#8217;s rare diseases support are as follows.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Global regulatory scenario <\/h2>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h3 style=\"text-decoration:underline;\"><a href=\"https:\/\/credevo.com\/articles\/2019\/12\/15\/rare-diseases-regulatory-incentives-for-development-of-orphan-drugs-us-europe\/\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\" (opens in a new tab)\">Rare Diseases: Regulatory Incentives for Development of Orphan Drugs &#8211; US &amp; EU<\/a><\/h3>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile has-vivid-cyan-blue-background-color has-background\" style=\"grid-template-columns:49% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Rare_disease_regulatory_incentives_for_orphan_drug_development_US_EU_credevo-1024x576.png\" alt=\"Rare_disease_regulatory_incentives_for_orphan_drug_development_US_EU_credevo\" class=\"wp-image-2163 size-full\" srcset=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Rare_disease_regulatory_incentives_for_orphan_drug_development_US_EU_credevo-1024x576.png 1024w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Rare_disease_regulatory_incentives_for_orphan_drug_development_US_EU_credevo-300x169.png 300w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Rare_disease_regulatory_incentives_for_orphan_drug_development_US_EU_credevo-768x432.png 768w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Rare_disease_regulatory_incentives_for_orphan_drug_development_US_EU_credevo-732x412.png 732w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Rare_disease_regulatory_incentives_for_orphan_drug_development_US_EU_credevo-1140x641.png 1140w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Rare_disease_regulatory_incentives_for_orphan_drug_development_US_EU_credevo.png 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"has-very-light-gray-color has-text-color\"><a href=\"https:\/\/credevo.com\/articles\/2019\/12\/15\/rare-diseases-regulatory-incentives-for-development-of-orphan-drugs-us-europe\/\">Click to learn about various incentives and regulatory support offered for rare disease research in the US &amp; Europe<\/a><\/p>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h3 style=\"text-decoration:underline;\"><a href=\"https:\/\/credevo.com\/articles\/2020\/01\/15\/rare-diseases-regulatory-incentives-for-development-of-orphan-drugs-japan-australia\/\">Rare Diseases: Regulatory Incentives for Development of Orphan Drugs &#8211; Japan &amp; Australia<\/a><\/h3>\n\n\n\n<div class=\"wp-block-media-text alignwide has-media-on-the-right is-stacked-on-mobile has-vivid-cyan-blue-background-color has-background\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Rarediseases_orphandrugs_designation_incentives_australia_japan_credevo-1024x576.png\" alt=\"\" class=\"wp-image-2234 size-full\" srcset=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Rarediseases_orphandrugs_designation_incentives_australia_japan_credevo-1024x576.png 1024w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Rarediseases_orphandrugs_designation_incentives_australia_japan_credevo-300x169.png 300w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Rarediseases_orphandrugs_designation_incentives_australia_japan_credevo-768x432.png 768w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Rarediseases_orphandrugs_designation_incentives_australia_japan_credevo-732x412.png 732w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Rarediseases_orphandrugs_designation_incentives_australia_japan_credevo-1140x641.png 1140w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Rarediseases_orphandrugs_designation_incentives_australia_japan_credevo.png 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"has-very-light-gray-color has-text-color\"><a href=\"https:\/\/credevo.com\/articles\/2020\/01\/15\/rare-diseases-regulatory-incentives-for-development-of-orphan-drugs-japan-australia\/\">Click here to discover the incentives and regulatory support you can get for rare disease research in Japan &amp; Australia<\/a> <\/p>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h3 style=\"text-decoration:underline;><a href=\"https:\/\/credevo.com\/articles\/2020\/02\/15\/rare-diseases-regulatory-incentives-for-development-of-orphan-drugs-china-india-russia-south-korea\/\">Rare Diseases: Regulatory Incentives for Development of Orphan Drugs &#8211; Asia<\/a><\/h3>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile has-vivid-cyan-blue-background-color has-background\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Raredisease_orphandrug_designation_regulatory_china_russia_india_southkorea_credevo-1024x576.png\" alt=\"\" class=\"wp-image-2284 size-full\" srcset=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Raredisease_orphandrug_designation_regulatory_china_russia_india_southkorea_credevo-1024x576.png 1024w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Raredisease_orphandrug_designation_regulatory_china_russia_india_southkorea_credevo-300x169.png 300w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Raredisease_orphandrug_designation_regulatory_china_russia_india_southkorea_credevo-768x432.png 768w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Raredisease_orphandrug_designation_regulatory_china_russia_india_southkorea_credevo-732x412.png 732w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Raredisease_orphandrug_designation_regulatory_china_russia_india_southkorea_credevo-1140x641.png 1140w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/Raredisease_orphandrug_designation_regulatory_china_russia_india_southkorea_credevo.png 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"has-very-light-gray-color has-text-color\"><a href=\"https:\/\/credevo.com\/articles\/2020\/02\/15\/rare-diseases-regulatory-incentives-for-development-of-orphan-drugs-china-india-russia-south-korea\/\">Click here to explore initiatives by regulatory agencies to support rare disease research in countries like China, India, Russia &amp; South Korea<\/a><\/p>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h3 style=\"text-decoration:underline;><a href=\"https:\/\/credevo.com\/articles\/2019\/10\/14\/this-is-the-primary-challenge-in-rare-disease-clinical-trials-and-a-ready-solution-is-available\/\">Rare Diseases: Primary challenges in rare disease clinical trials and solution<\/a><\/h3>\n\n\n\n<div class=\"wp-block-media-text alignwide has-media-on-the-right is-stacked-on-mobile has-vivid-cyan-blue-background-color has-background\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/10\/Art3-1024x576.png\" alt=\"\" class=\"wp-image-1775 size-full\" srcset=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/10\/Art3-1024x576.png 1024w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/10\/Art3-300x169.png 300w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/10\/Art3-768x432.png 768w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/10\/Art3-732x412.png 732w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/10\/Art3-1140x641.png 1140w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/10\/Art3.png 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"has-very-light-gray-color has-text-color\"><a href=\"https:\/\/credevo.com\/articles\/2019\/10\/14\/this-is-the-primary-challenge-in-rare-disease-clinical-trials-and-a-ready-solution-is-available\/\">Click here to learn about the primary challenges such as patient recruitment in rare disease clinical trials and a possible solution to overcome those challenges<\/a><\/p>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h3 style=\"text-decoration:underline;><a href=\"https:\/\/credevo.com\/articles\/2019\/04\/16\/rare-diseases-clinical-trials-drug-development\/(opens in a new tab)\">Rare Diseases: Clinical Trials &amp; Drug Development<\/a> <\/h3>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile has-vivid-cyan-blue-background-color has-background\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/03\/Clinical_trials_rare_disease_credevo-1-1024x576.jpg\" alt=\"\" class=\"wp-image-1415 size-full\" srcset=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/03\/Clinical_trials_rare_disease_credevo-1-1024x576.jpg 1024w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/03\/Clinical_trials_rare_disease_credevo-1-300x169.jpg 300w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/03\/Clinical_trials_rare_disease_credevo-1-768x432.jpg 768w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/03\/Clinical_trials_rare_disease_credevo-1-732x412.jpg 732w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/03\/Clinical_trials_rare_disease_credevo-1-1140x641.jpg 1140w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/03\/Clinical_trials_rare_disease_credevo-1.jpg 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"has-very-light-gray-color has-text-color\"><a href=\"https:\/\/credevo.com\/articles\/2019\/04\/16\/rare-diseases-clinical-trials-drug-development\/\">Click here to find various aspects involved in designing clinical trials &amp; development in rare diseases<\/a><\/p>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Feasibility studies in rare diseases<\/h2>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h3 style=\"text-decoration:underline;><a href=\"https:\/\/credevo.com\/articles\/2018\/05\/30\/glomerulonephritis-clinical-trial-feasibility\/\">Clinical trial feasibility: Glomerulonephritis<\/a><\/h3>\n\n\n\n<div class=\"wp-block-media-text alignwide has-media-on-the-right is-stacked-on-mobile has-vivid-cyan-blue-background-color has-background\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/11\/Glomerulonephritis_clinical_trial_feasibility_credevo-1024x576.jpg\" alt=\"\" class=\"wp-image-869 size-full\" srcset=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/11\/Glomerulonephritis_clinical_trial_feasibility_credevo-1024x576.jpg 1024w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/11\/Glomerulonephritis_clinical_trial_feasibility_credevo-300x169.jpg 300w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/11\/Glomerulonephritis_clinical_trial_feasibility_credevo-768x432.jpg 768w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/11\/Glomerulonephritis_clinical_trial_feasibility_credevo-732x412.jpg 732w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/11\/Glomerulonephritis_clinical_trial_feasibility_credevo-1140x641.jpg 1140w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/11\/Glomerulonephritis_clinical_trial_feasibility_credevo.jpg 1280w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"has-very-light-gray-color has-text-color\"><a href=\"https:\/\/credevo.com\/articles\/2018\/05\/30\/glomerulonephritis-clinical-trial-feasibility\/\">Click here to find a clinical trial feasibility study that was performed on Credevo which received overwhelming responses from various clinical investigator&#8217;s and sites<\/a> <\/p>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h3 style=\"text-decoration:underline;><a href=\"https:\/\/credevo.com\/articles\/2018\/02\/28\/acute-myeloid-leukemia-phase-iii-clinical-trial-feasibility\/(opens in a new tab)\">Clinical trial feasibility: Acute Myeloid Leukemia (AML)<\/a><\/h3>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile has-vivid-cyan-blue-background-color has-background\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"548\" src=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/02\/acute_myeloid_leukemia_clinical_trial_feasibility_Credevo-1024x548.jpg\" alt=\"acute_myeloid_leukemia_clinical_trial_feasibility_Credevo\" class=\"wp-image-565 size-full\" srcset=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/02\/acute_myeloid_leukemia_clinical_trial_feasibility_Credevo-1024x548.jpg 1024w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/02\/acute_myeloid_leukemia_clinical_trial_feasibility_Credevo-300x161.jpg 300w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/02\/acute_myeloid_leukemia_clinical_trial_feasibility_Credevo-768x411.jpg 768w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/02\/acute_myeloid_leukemia_clinical_trial_feasibility_Credevo-732x392.jpg 732w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/02\/acute_myeloid_leukemia_clinical_trial_feasibility_Credevo-1140x610.jpg 1140w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/02\/acute_myeloid_leukemia_clinical_trial_feasibility_Credevo.jpg 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"has-very-light-gray-color has-text-color\"><a href=\"https:\/\/credevo.com\/articles\/2018\/02\/28\/acute-myeloid-leukemia-phase-iii-clinical-trial-feasibility\/\">Click here to explore the Acute Myeloid Leukemia phase I\/II feasibility study which<\/a><a href=\"https:\/\/credevo.com\/articles\/2018\/02\/28\/acute-myeloid-leukemia-phase-iii-clinical-trial-feasibility\/(opens in a new tab)\"> was preformed for clinical investigator&#8217;s and sites located in Canada<\/a><\/p>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h3 style=\"text-decoration:underline;><a href=\"https:\/\/credevo.com\/articles\/2018\/01\/30\/epidermolysis-bullosa-clinical-trial-feasibility\/\">Clinical trial feasibility: Epidermolysis Bullosa (EB)<\/a><\/h3>\n\n\n\n<div class=\"wp-block-media-text alignwide has-media-on-the-right is-stacked-on-mobile has-vivid-cyan-blue-background-color has-background\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"548\" src=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/01\/epidermolysis_bullosa_clinical_trial_feasibility_credevo-1024x548.png\" alt=\"\" class=\"wp-image-713 size-full\" srcset=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/01\/epidermolysis_bullosa_clinical_trial_feasibility_credevo-1024x548.png 1024w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/01\/epidermolysis_bullosa_clinical_trial_feasibility_credevo-300x161.png 300w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/01\/epidermolysis_bullosa_clinical_trial_feasibility_credevo-768x411.png 768w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/01\/epidermolysis_bullosa_clinical_trial_feasibility_credevo-732x392.png 732w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/01\/epidermolysis_bullosa_clinical_trial_feasibility_credevo-1140x610.png 1140w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/01\/epidermolysis_bullosa_clinical_trial_feasibility_credevo.png 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"has-very-light-gray-color has-text-color\"><a href=\"https:\/\/credevo.com\/articles\/2018\/01\/30\/epidermolysis-bullosa-clinical-trial-feasibility\/\">A clinical trial on Epidermolysis bullosa was explored at different  medical centers and sites located in USA, India, South Africa, Australia, Denmark, Norway and Canada. <\/a><\/p>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h3 style=\"text-decoration:underline;><a href=\"https:\/\/credevo.com\/articles\/2017\/11\/20\/amyotrophic-lateral-sclerosis-potentially-high-clinical-trial-recruitment-with-investigators-in-canada\/\">Clinical trial feasibility: Amyotrophic Lateral Sclerosis  (ALS)<\/a><\/h3>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile has-vivid-cyan-blue-background-color has-background\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"548\" src=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/11\/Amyotrophic_Lateral_Sclerosis_feasibility_canada_credevo-1024x548.jpg\" alt=\"\" class=\"wp-image-490 size-full\" srcset=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/11\/Amyotrophic_Lateral_Sclerosis_feasibility_canada_credevo-1024x548.jpg 1024w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/11\/Amyotrophic_Lateral_Sclerosis_feasibility_canada_credevo-300x161.jpg 300w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/11\/Amyotrophic_Lateral_Sclerosis_feasibility_canada_credevo-768x411.jpg 768w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/11\/Amyotrophic_Lateral_Sclerosis_feasibility_canada_credevo-732x392.jpg 732w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/11\/Amyotrophic_Lateral_Sclerosis_feasibility_canada_credevo-1140x610.jpg 1140w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/11\/Amyotrophic_Lateral_Sclerosis_feasibility_canada_credevo.jpg 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"has-very-light-gray-color has-text-color\"><a href=\"https:\/\/credevo.com\/articles\/2017\/11\/20\/amyotrophic-lateral-sclerosis-potentially-high-clinical-trial-recruitment-with-investigators-in-canada\/\">Click here to learn about a Clinical trial feasibility&nbsp;Phase III study in Amyotrophic Lateral Sclerosis (ALS) for clinical investigator&#8217;s &amp; sites in Canada<\/a><\/p>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h3 style=\"text-decoration:underline;><a href=\"https:\/\/credevo.com\/articles\/2019\/11\/17\/clinical-trial-logistics-rare-disease-clinical-trials\/\">Rare disease services: Clinical trial logistics<\/a><\/h3>\n\n\n\n<div class=\"wp-block-media-text alignwide has-media-on-the-right is-stacked-on-mobile has-vivid-cyan-blue-background-color has-background\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/11\/Supply_Chain_Management_in_Clinical_Trials_for_Rare_Diseases_Credevo-1024x576.png\" alt=\"\" class=\"wp-image-2138 size-full\" srcset=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/11\/Supply_Chain_Management_in_Clinical_Trials_for_Rare_Diseases_Credevo-1024x576.png 1024w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/11\/Supply_Chain_Management_in_Clinical_Trials_for_Rare_Diseases_Credevo-300x169.png 300w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/11\/Supply_Chain_Management_in_Clinical_Trials_for_Rare_Diseases_Credevo-768x432.png 768w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/11\/Supply_Chain_Management_in_Clinical_Trials_for_Rare_Diseases_Credevo-732x412.png 732w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/11\/Supply_Chain_Management_in_Clinical_Trials_for_Rare_Diseases_Credevo-1140x641.png 1140w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/11\/Supply_Chain_Management_in_Clinical_Trials_for_Rare_Diseases_Credevo.png 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"has-very-light-gray-color has-text-color\"><a href=\"https:\/\/credevo.com\/articles\/2019\/11\/17\/clinical-trial-logistics-rare-disease-clinical-trials\/\">Credevo offers special logistics services in rare disease clinical trials which require more sophisticated management system to overcome the challenges that arise in rare disease clinical trials<\/a>  <\/p>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n<blockquote class=\"wp-block-quote\">\n<h1><strong>Are you looking for regulatory support for your drug development in rare diseases?<\/strong><\/h1>\n<p>Talk to us today. Provide details of your requirements and we will connect with you.<\/p>\n<div class=\"wpforms-container wpforms-container-full\" id=\"wpforms-2348\"><form id=\"wpforms-form-2348\" class=\"wpforms-validate wpforms-form\" data-formid=\"2348\" method=\"post\" enctype=\"multipart\/form-data\" action=\"\/articles\/wp-json\/wp\/v2\/posts\/2296\" data-token=\"fb3d04500f22b25fc91a316e84124b5b\" data-token-time=\"1775987186\"><noscript class=\"wpforms-error-noscript\">Please enable JavaScript in your browser to complete this form.<\/noscript><div class=\"wpforms-field-container\"><div id=\"wpforms-2348-field_7-container\" class=\"wpforms-field wpforms-field-textarea\" data-field-id=\"7\"><label class=\"wpforms-field-label\" for=\"wpforms-2348-field_7\">Provide details about your requirements <span class=\"wpforms-required-label\">*<\/span><\/label><textarea id=\"wpforms-2348-field_7\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][7]\" required><\/textarea><\/div><div id=\"wpforms-2348-field_1-container\" class=\"wpforms-field wpforms-field-email\" data-field-id=\"1\"><label class=\"wpforms-field-label\" for=\"wpforms-2348-field_1\">What is your work email? <span class=\"wpforms-required-label\">*<\/span><\/label><input type=\"email\" id=\"wpforms-2348-field_1\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][1]\" spellcheck=\"false\" required><div class=\"wpforms-field-description\">Provide your work email, where we can contact you<\/div><\/div><\/div><!-- .wpforms-field-container --><div class=\"wpforms-field wpforms-field-hp\"><label for=\"wpforms-2348-field-hp\" class=\"wpforms-field-label\">Message<\/label><input type=\"text\" name=\"wpforms[hp]\" id=\"wpforms-2348-field-hp\" class=\"wpforms-field-medium\"><\/div><div class=\"wpforms-recaptcha-container wpforms-is-recaptcha wpforms-is-recaptcha-type-v2\" ><div class=\"g-recaptcha\" data-sitekey=\"6LeaQRYTAAAAAPo7U8jnZJBUndxcS3f0E3Vijb2k\"><\/div><input type=\"text\" name=\"g-recaptcha-hidden\" class=\"wpforms-recaptcha-hidden\" style=\"position:absolute!important;clip:rect(0,0,0,0)!important;height:1px!important;width:1px!important;border:0!important;overflow:hidden!important;padding:0!important;margin:0!important;\" data-rule-recaptcha=\"1\"><\/div><div class=\"wpforms-submit-container\" ><input type=\"hidden\" name=\"wpforms[id]\" value=\"2348\"><input type=\"hidden\" name=\"page_title\" value=\"\"><input type=\"hidden\" name=\"page_url\" value=\"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/posts\/2296\"><input type=\"hidden\" name=\"url_referer\" value=\"\"><button type=\"submit\" name=\"wpforms[submit]\" id=\"wpforms-submit-2348\" class=\"wpforms-submit\" data-alt-text=\"Sending...\" data-submit-text=\"Submit\" aria-live=\"assertive\" value=\"wpforms-submit\">Submit<\/button><\/div><\/form><\/div>  <!-- .wpforms-container -->\n<\/blockquote>\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">References<\/h3>\n\n\n\n<ol class=\"wp-block-list\"><li><a href=\"https:\/\/www.rarediseaseday.org\/article\/what-is-a-rare-disease\">https:\/\/www.rarediseaseday.org\/article\/what-is-a-rare-disease<\/a><\/li><li><a href=\"https:\/\/en.wikipedia.org\/wiki\/Rare_Disease_Day\">https:\/\/en.wikipedia.org\/wiki\/Rare_Disease_Day<\/a> <\/li><li><a href=\"https:\/\/williams-syndrome.org\/rare-disease-day-2018\">https:\/\/williams-syndrome.org\/rare-disease-day-2018<\/a> <\/li><li><a href=\"https:\/\/www.wheelsforwishes.org\/news\/11-facts-about-rare-disease-day-2017\/?__cf_chl_captcha_tk__=59d163cc298a60aba52d7231bcc6af1a3b5854ea-1582535699-0-ARoHMoi4kE24DxVkVFzWq2ND4Wwq_XlmZEn12KbtWSbQpiWIo09LXQQPQ2PRAgse6t67uykRofqfLuVIYa07g2ilTIJPL8n_R-5nssDHdKjJFOOWr1tVchEvYGcRcvIomm4gBNwA-EJkiZ5DFPhz_fnNGCi3GtW12TuVgjpgbTnu35EuJV6ElENqOuWkHYwf2vUy--oFd-RqBOnXlgxjS06mY4-w4ToSvSgjZex5N5lW22xaThtqMNTmmPiuGL3lREWSZTBT0vQ1qGi0H4B8t7ONIbkClyYa39pc2bBVHJrmcKqeJsea4VIgypvGo4XIgS8-3tQta2GvF3XqsVl7Slq0vbD3Kh3pz4j02EmfUAY9_lmFF77tYULpAEwQBw3v9Q\">https:\/\/www.wheelsforwishes.org\/news\/11-facts-about-rare-disease-day-2017<\/a><a href=\"https:\/\/www.wheelsforwishes.org\/news\/11-facts-about-rare-disease-day-2017\">\/<\/a><\/li><\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Many people with rare diseases struggle to find the right diagnosis and right treatment for years. The lack of awareness about these conditions makes it much harder for them to get the right treatment. Rare Disease Day is all about raising awareness for rare diseases. And, this year, you can join these efforts too. The [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"cybocfi_hide_featured_image":"","footnotes":""},"categories":[2,13,12,14],"tags":[45,283,34,218,284,148,291,255,82],"class_list":["post-2296","post","type-post","status-publish","format-standard","hentry","category-clinical-research","category-clinical-site","category-clinical-trial","category-clinical-trial-feasibility","tag-clinicaltrials","tag-ema","tag-fda","tag-orphandrug","tag-orphandrugs","tag-pmda","tag-rarediseaseday","tag-rarediseases","tag-tga"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Rare Disease Day 2020: Taking a step further | Credevo Articles<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rare Disease Day 2020: Taking a step further | Credevo Articles\" \/>\n<meta property=\"og:description\" content=\"Many people with rare diseases struggle to find the right diagnosis and right treatment for years. The lack of awareness about these conditions makes it much harder for them to get the right treatment. Rare Disease Day is all about raising awareness for rare diseases. And, this year, you can join these efforts too. The [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/\" \/>\n<meta property=\"og:site_name\" content=\"Credevo Articles\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/credevo\" \/>\n<meta property=\"article:published_time\" content=\"2020-02-28T10:40:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-08-18T12:50:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/rarediseaseday_feb29_2020_13th_orphandrug_credevo-1024x576.png\" \/>\n<meta name=\"author\" content=\"Trial Expert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@gocredevo\" \/>\n<meta name=\"twitter:site\" content=\"@gocredevo\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trial Expert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/\"},\"author\":{\"name\":\"Trial Expert\",\"@id\":\"https:\/\/credevo.com\/articles\/#\/schema\/person\/27532d20071183286988a29ea878a2ec\"},\"headline\":\"Rare Disease Day 2020: Taking a step further\",\"datePublished\":\"2020-02-28T10:40:48+00:00\",\"dateModified\":\"2021-08-18T12:50:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/\"},\"wordCount\":863,\"publisher\":{\"@id\":\"https:\/\/credevo.com\/articles\/#organization\"},\"image\":{\"@id\":\"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/rarediseaseday_feb29_2020_13th_orphandrug_credevo-1024x576.png\",\"keywords\":[\"clinicaltrials\",\"EMA\",\"FDA\",\"orphandrug\",\"Orphandrugs\",\"PMDA\",\"rarediseaseday\",\"rarediseases\",\"TGA\"],\"articleSection\":[\"Clinical Research\",\"clinical site\",\"clinical trial\",\"clinical trial feasibility\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/\",\"url\":\"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/\",\"name\":\"Rare Disease Day 2020: Taking a step further | Credevo Articles\",\"isPartOf\":{\"@id\":\"https:\/\/credevo.com\/articles\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/rarediseaseday_feb29_2020_13th_orphandrug_credevo-1024x576.png\",\"datePublished\":\"2020-02-28T10:40:48+00:00\",\"dateModified\":\"2021-08-18T12:50:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/#primaryimage\",\"url\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/rarediseaseday_feb29_2020_13th_orphandrug_credevo.png\",\"contentUrl\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/rarediseaseday_feb29_2020_13th_orphandrug_credevo.png\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/credevo.com\/articles\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rare Disease Day 2020: Taking a step further\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/credevo.com\/articles\/#website\",\"url\":\"https:\/\/credevo.com\/articles\/\",\"name\":\"Credevo\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/credevo.com\/articles\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/credevo.com\/articles\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/credevo.com\/articles\/#organization\",\"name\":\"Credevo Pte. Ltd.\",\"url\":\"https:\/\/credevo.com\/articles\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/credevo.com\/articles\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2021\/04\/CREDEVO-HORIZONTAL.jpg\",\"contentUrl\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2021\/04\/CREDEVO-HORIZONTAL.jpg\",\"width\":320,\"height\":119,\"caption\":\"Credevo Pte. Ltd.\"},\"image\":{\"@id\":\"https:\/\/credevo.com\/articles\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/credevo\",\"https:\/\/x.com\/gocredevo\",\"https:\/\/www.instagram.com\/credevo_official\/\",\"https:\/\/www.linkedin.com\/company\/credevo\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/credevo.com\/articles\/#\/schema\/person\/27532d20071183286988a29ea878a2ec\",\"name\":\"Trial Expert\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/credevo.com\/articles\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/07b120d666645220d4fd5b49e154d849?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/07b120d666645220d4fd5b49e154d849?s=96&d=mm&r=g\",\"caption\":\"Trial Expert\"},\"url\":\"https:\/\/credevo.com\/articles\/author\/trialexpert\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rare Disease Day 2020: Taking a step further | Credevo Articles","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/","og_locale":"en_US","og_type":"article","og_title":"Rare Disease Day 2020: Taking a step further | Credevo Articles","og_description":"Many people with rare diseases struggle to find the right diagnosis and right treatment for years. The lack of awareness about these conditions makes it much harder for them to get the right treatment. Rare Disease Day is all about raising awareness for rare diseases. And, this year, you can join these efforts too. The [&hellip;]","og_url":"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/","og_site_name":"Credevo Articles","article_publisher":"https:\/\/www.facebook.com\/credevo","article_published_time":"2020-02-28T10:40:48+00:00","article_modified_time":"2021-08-18T12:50:04+00:00","og_image":[{"url":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/rarediseaseday_feb29_2020_13th_orphandrug_credevo-1024x576.png"}],"author":"Trial Expert","twitter_card":"summary_large_image","twitter_creator":"@gocredevo","twitter_site":"@gocredevo","twitter_misc":{"Written by":"Trial Expert","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/#article","isPartOf":{"@id":"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/"},"author":{"name":"Trial Expert","@id":"https:\/\/credevo.com\/articles\/#\/schema\/person\/27532d20071183286988a29ea878a2ec"},"headline":"Rare Disease Day 2020: Taking a step further","datePublished":"2020-02-28T10:40:48+00:00","dateModified":"2021-08-18T12:50:04+00:00","mainEntityOfPage":{"@id":"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/"},"wordCount":863,"publisher":{"@id":"https:\/\/credevo.com\/articles\/#organization"},"image":{"@id":"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/#primaryimage"},"thumbnailUrl":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/rarediseaseday_feb29_2020_13th_orphandrug_credevo-1024x576.png","keywords":["clinicaltrials","EMA","FDA","orphandrug","Orphandrugs","PMDA","rarediseaseday","rarediseases","TGA"],"articleSection":["Clinical Research","clinical site","clinical trial","clinical trial feasibility"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/","url":"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/","name":"Rare Disease Day 2020: Taking a step further | Credevo Articles","isPartOf":{"@id":"https:\/\/credevo.com\/articles\/#website"},"primaryImageOfPage":{"@id":"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/#primaryimage"},"image":{"@id":"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/#primaryimage"},"thumbnailUrl":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/rarediseaseday_feb29_2020_13th_orphandrug_credevo-1024x576.png","datePublished":"2020-02-28T10:40:48+00:00","dateModified":"2021-08-18T12:50:04+00:00","breadcrumb":{"@id":"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/#primaryimage","url":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/rarediseaseday_feb29_2020_13th_orphandrug_credevo.png","contentUrl":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2020\/02\/rarediseaseday_feb29_2020_13th_orphandrug_credevo.png","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/credevo.com\/articles\/2020\/02\/28\/rare-disease-day-2020-taking-a-step-further\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/credevo.com\/articles\/"},{"@type":"ListItem","position":2,"name":"Rare Disease Day 2020: Taking a step further"}]},{"@type":"WebSite","@id":"https:\/\/credevo.com\/articles\/#website","url":"https:\/\/credevo.com\/articles\/","name":"Credevo","description":"","publisher":{"@id":"https:\/\/credevo.com\/articles\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/credevo.com\/articles\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/credevo.com\/articles\/#organization","name":"Credevo Pte. Ltd.","url":"https:\/\/credevo.com\/articles\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/credevo.com\/articles\/#\/schema\/logo\/image\/","url":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2021\/04\/CREDEVO-HORIZONTAL.jpg","contentUrl":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2021\/04\/CREDEVO-HORIZONTAL.jpg","width":320,"height":119,"caption":"Credevo Pte. Ltd."},"image":{"@id":"https:\/\/credevo.com\/articles\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/credevo","https:\/\/x.com\/gocredevo","https:\/\/www.instagram.com\/credevo_official\/","https:\/\/www.linkedin.com\/company\/credevo"]},{"@type":"Person","@id":"https:\/\/credevo.com\/articles\/#\/schema\/person\/27532d20071183286988a29ea878a2ec","name":"Trial Expert","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/credevo.com\/articles\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/07b120d666645220d4fd5b49e154d849?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/07b120d666645220d4fd5b49e154d849?s=96&d=mm&r=g","caption":"Trial Expert"},"url":"https:\/\/credevo.com\/articles\/author\/trialexpert\/"}]}},"_links":{"self":[{"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/posts\/2296"}],"collection":[{"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/comments?post=2296"}],"version-history":[{"count":67,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/posts\/2296\/revisions"}],"predecessor-version":[{"id":6508,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/posts\/2296\/revisions\/6508"}],"wp:attachment":[{"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/media?parent=2296"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/categories?post=2296"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/tags?post=2296"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}